Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Durieu

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Revue Des Maladies Respiratoires|June 19, 2019
[Quality criteria for the transition to adult care in French CF centers - results from the SAFETIM APP study?]V Vion Genovese, M Perceval, L Buscarlet-Jardine, et al.
La Revue De Medecine Interne|January 1, 1997
[Dementia syndrome of recent appearance...]T Zenone, A Revol, I Durieu, et al.
The European Respiratory Journal|February 16, 2007
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosisI Durieu, F Abbas-Chorfa, J Drai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2016
Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphismF Magne, S Durupt, R Nove-Josserand, et al.
Contraception|December 2, 2019
Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultationC Rousset-Jablonski, Q Reynaud, M Perceval, et al.
Presse Medicale (Paris, France : 1983)|October 14, 1995
[Vascular and/or cardiac manifestations of type IV Ehlers-Danlos syndrome. 9 cases]B de Wazières, B Coppere, I Durieu, et al.
La Revue De Medecine Interne|April 15, 2008
[Tropheryma whipplei and Whipple disease: false positive PCR detections of Tropheryma whipplei in diagnostic samples are rare]J Le Scanff, J B Gaultier, D Vital Durand, et al.
La Revue De Medecine Interne|July 7, 2020
[Functional immunoassays in the setting of infectious risk and immunosuppressive therapy of non-HIV immunocompromised patients]M Boccard, C Albert-Vega, W Mouton, et al.
Revue Neurologique|December 1, 1995
[Progressive lupus dementia. 2 cases with or without antiphospholipid antibodies]C Robin, P M Gonnaud, I Durieu, et al.
Circulation|May 23, 2001
Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosisL Pinede, J Ninet, P Duhaut, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Revue Des Maladies Respiratoires|June 19, 2019
[Quality criteria for the transition to adult care in French CF centers - results from the SAFETIM APP study?]V Vion Genovese, M Perceval, L Buscarlet-Jardine, et al.
La Revue De Medecine Interne|January 1, 1997
[Dementia syndrome of recent appearance...]T Zenone, A Revol, I Durieu, et al.
The European Respiratory Journal|February 16, 2007
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosisI Durieu, F Abbas-Chorfa, J Drai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2016
Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphismF Magne, S Durupt, R Nove-Josserand, et al.
Contraception|December 2, 2019
Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultationC Rousset-Jablonski, Q Reynaud, M Perceval, et al.
Presse Medicale (Paris, France : 1983)|October 14, 1995
[Vascular and/or cardiac manifestations of type IV Ehlers-Danlos syndrome. 9 cases]B de Wazières, B Coppere, I Durieu, et al.
La Revue De Medecine Interne|April 15, 2008
[Tropheryma whipplei and Whipple disease: false positive PCR detections of Tropheryma whipplei in diagnostic samples are rare]J Le Scanff, J B Gaultier, D Vital Durand, et al.
La Revue De Medecine Interne|July 7, 2020
[Functional immunoassays in the setting of infectious risk and immunosuppressive therapy of non-HIV immunocompromised patients]M Boccard, C Albert-Vega, W Mouton, et al.
Revue Neurologique|December 1, 1995
[Progressive lupus dementia. 2 cases with or without antiphospholipid antibodies]C Robin, P M Gonnaud, I Durieu, et al.
Circulation|May 23, 2001
Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosisL Pinede, J Ninet, P Duhaut, et al.
Pageof 13